Rangeley Capital’s CARGO Therapeutics CRGX Stock Holding History

Rangeley Capital’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,851	Closed	-$172K	–	130
2025 Q2	$172K	Sell	41,851 -40,000	-49%	-$171K	0.21%	51
2025 Q1	$333K	Buy	+81,851	New	+$548K	0.36%	44

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rangeley Capital's CRGX Position: Q3 2025 in Review

Rangeley Capital sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 41,851 shares — an estimated $172K sold.

Rangeley Capital first reported a position in CRGX in Q1 2025 and held it in 2 quarters. The position peaked at $333K in Q1 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Rangeley Capital reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Rangeley Capital sold 41,851 CARGO Therapeutics shares in Q3 2025, an estimated $172K.
Rangeley Capital first reported a position in CARGO Therapeutics in Q1 2025 and held it in 2 quarters.
Rangeley Capital's CARGO Therapeutics position peaked at $333K in Q1 2025.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.